Cyberonics Inc. said Dec. 18 medical device maker Ethicon Endo-Surgery agreed to pay Cyberonics $9.5 million plus royalties to license its patents related to obesity treatment. Cyberonics develops medical devices that provide vagus nerve stimulation, a nondrug treatment currently approved for use in treatment-resistant epilepsy and depression.
December 26, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Cyberonics Inc. said Dec. 18 medical device maker Ethicon Endo-Surgery agreed to pay Cyberonics $9.5 million plus royalties to license its patents related to obesity treatment.
Cyberonics develops medical devices that provide vagus nerve stimulation, a nondrug treatment currently approved for use in treatment-resistant epilepsy and depression.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
